Cognition and Smoking Relapse (HCS)

CompletedOBSERVATIONAL
Enrollment

274

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

April 21, 2022

Study Completion Date

April 25, 2022

Conditions
Smoking Cessation
Interventions
DRUG

Nicotine patch

"All participants will receive nicotine patches to aid in quitting smoking. TN is available over the counter and is very well tolerated. Participants will use the patch in a tapering fashion as recommended by the manufacturer. Participants who smoke 10 or more cigarettes per day will adhere to the following dosing guidelines: 21 mg for 4 weeks; 14 mg for 2 weeks and 7 mg for 2 weeks. Individuals who smoke between 5 and 9 cigarettes per day will follow a modified dosing regimen: 14 mg for 6 weeks and 7 mg for 2 weeks."

BEHAVIORAL

Behavioral counseling

Participants will attend 6 counseling sessions and receive standard smoking cessation counseling (SC).

Trial Locations (1)

19104

Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pennsylvania

OTHER

NCT03169101 - Cognition and Smoking Relapse (HCS) | Biotech Hunter | Biotech Hunter